Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fernando José Goes Ruiz"'
Autor:
Giovanni Faria Silva, Cristiane A. Villela-Nogueira, Carlos Eduardo Brandão Mello, Elza Cotrim Soares, Henrique Sergio M. Coelho, Paulo Roberto Abrão Ferreira, Fernando José Goes Ruiz
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 18, Iss 1, Pp 48-52 (2014)
Background: Tolerance and response to antiviral HCV treatment is poor in advanced fibrosis. The aim of this study was to assess SVR rate and its predictive factors in HCV advanced fibrosis patients treated in real life with full dose PEG-IFN plus RBV
Externí odkaz:
https://doaj.org/article/92eb872f683041b39bcbb970135b5abd
Autor:
Juliana Cristina Tangerino, Luciana Veríssimo Fernandes, Mariana Cunha de Ávila Camargo, Mariana Medina de Almeida, Fernando José Goes Ruiz
Publikováno v:
Revista da Faculdade de Ciências Médicas de Sorocaba, Vol 17, Iss Supl. (2015)
A infecção pelo vírus da hepatite C (HCV) consiste em um grande problema de saúde pública, pois o HCV leva à cirrose em mais de 20% dos casos. Nota-se um impacto do tratamento do HCV na qualidade de vida dos pacientes, visto frequentes relatos
Autor:
Fernando José Goes Ruiz
Publikováno v:
Revista da Faculdade de Ciências Médicas de Sorocaba, Vol 10, Iss 2 (2008)
Autor:
Fernando José Goes Ruiz
Publikováno v:
Revista da Faculdade de Ciências Médicas de Sorocaba, Vol 11, Iss 3, Pp 35-36 (2009)
Autor:
Leila Maria Moreira Beltrão Pereira, Jose Ramos, Fernando José Goes Ruiz, Mônica Valverde Viana, Fernando B. Serra, Ricardo Sobhie Diaz, Elson V. Martins, Maria Lucia Gomes Ferraz, Fabiane El-Far, Hamilton Bonilha, Giovanni Faria Silva
Publikováno v:
Gastroenterology. 138:S-845
BACKGROUND: The RVR following peginterferon alfa 2b and ribavirin is an important predictor of sustained virologic response (SVR) in chronic HCV infected patients (CHC). Identifying early on-treatment factors associated with SVR is therefore importan